SALES@REPORTOCEAN.COM
 +1 888 212 3539 (US - TOLL FREE)    +91 999 711 2116 (REST OF WORLD)
`

Assessment of Covid-19 Impact!!! Get FREE Updated report copy with market revised forecasts and anaysis highlighting shift in business startegies by key players to reinforce their industry position

Scaffold Technology Market Size, Share, Trends and Industry Analysis Report, By Product Type (Polymeric, Hydrogels, Micropatterned surface Microplates, Freeze Embryo Testing and Nanofiber- based); By Application; By End-use and By Regions: Segment Forecast 2019-2026

Scaffold Technology Market Size, Share, Trends and Industry Analysis Report, By Product Type (Polymeric, Hydrogels, Micropatterned surface Microplates, Freeze Embryo Testing and Nanofiber- based); By Application; By End-use and By Regions: Segment Forecast 2019-2026

Published date: 28-01-2020  Region: Global  Pages: 90  Format: Pdf  Publisher Name: Polaris Market Research and Consulting SKU: RO1/107/1059


The global scaffold technology market size is set to outnumber USD 1,484.8 million by 2026 growing at a CAGR of 10.38% during forecast period according to a new study published by Report Ocean. The report ‘Scaffold Technology Market Size, Share, Trends and Industry Analysis Report, By Product Type (Polymeric, Hydrogels, Micropatterned surface Microplates, Freeze Embryo Testing and Nanofiber- based); By Application; By End-use and By Regions: Segment Forecast 2019-2026’ provides an in-depth analysis of present market dynamics and envisioned future trends.


The global scaffold technology tissue engineering is registering high growth due to the rising number of minimally invasive surgeries for treating an increasing number of cancer patients across the globe.  Increasing investments from Government and regional bodies also attract market growth without compromising on R&D facilities in use of this technology.


Factors favoring scaffold technology market are an inherent bias towards regenerative technology coupled with a rising number of organ transplant cases to repair the damaged tissue or organs during the forecast period. Scaffolds are very much needed in treatment of damaged or lifeless organs to support implants that are operated into patients’ body.  The market is rather upbeat because of the use of technology. Rise in geriatric population causing organ failure which should be treated soon, causing an area of research using 3D Cell with application, collates further market growth.


Resorbable scaffold technology is divided based upon product type, application and end-use. The product type is further sub-divided into polymeric scaffolds, hydrogels, micropatterned surface microplates, freeze embryo testing and nano fiber-based scaffolds. Considering end-use, research laboratories and institutes, biotechnology and pharmaceutical organizations, hospital and diagnostic centers take dominant market position.


Scaffold technologies are fundamentally tissue engineering that seamlessly enter biological substitutes with applications for regenerative tissue repair or organ repair.  Product type includes cell attachments and migration, nutrients and product diffusion.


Hydrogel based scaffolds were very popular in use with abundant availability and round- the- clock development. Their unilateral acceptance in cartilage tissue scaffolds that helps growth of cells and drug delivery is attributed to their adoption.


By geography, scaffold technology is segmented into five major regions namely North America, Europe, Asia pacific, Latin America and Middle East and Africa. North America leads the market due to high prevalence of cancer in the region taking a huge death toll. According to global estimates by WHO, cancer is the leading cause of death accounting for 9.6 million deaths in 2018 that will further drive market growth. Copious investments by Government in R&D facilities to nurture this technology will profusely support market growth.


Asia pacific will display high growth owing to Government investments in development of healthcare infrastructure and controlled policies in promoting use of this technology. Increasing prevalence of cancer in Asia pacific and increasing awareness for adoption of organ transplant will also add impetus to the market. Rising number of smoking populace and alcohol abuse due to lifestyle changes has powered Asia pacific market.


Key findings in the scaffold technology market indicate rapid strides by companies in technology pursuits.  Companies leverage factors such as increasing awareness in treating   abundance of chronic diseases and also awareness of organ transplant in developing countries, in an endeavor to bring new and advanced technologies to the fore.


The key players in scaffold technology market include Merck and Company, Thermo Fischer Scientific INc., 3D Biotec LLC, Pelo Biotec GmbH, Corning Inc., Avacta Life Sciences Limited, Nanofiber Solutions, Nuvasive, Inc., Tecan Trading AG and Molecular Matrix Inc. among others.


Report Ocean has segmented the global scaffold technology market on the basis of product type, application, end-use and region.


Scaffold Technology Product type Outlook (Revenue USD Millions 2015-2026)


Polymeric scaffolds


Hydrogels


Micropatterned surface microplates


Freeze embryo testing


Nano fiber-based scaffolds


Scaffold Technology Application Outlook (Revenue USD Millions 2015-2026)


Drug development


Stem cell research


Cancer


Tissue engineering and clinical application


Others


Scaffold Technology End-use Outlook (Revenue USD Millions 2015-2026)


Research Laboratories and Institutes


Biotechnology and Pharmaceutical Organizations


Hospitals and Diagnosis Centers


Others


Scaffold Technology Regional Outlook (Revenue USD Millions 2015-2026)


North America


US


Canada


Europe


Germany


UK


France


Italy


Spain


Asia-Pacific


China


India


Japan


Latin America


Mexico


Brazil


Middle East and Africa


Table of Contents

1.Overview and Scope

1.1.Research goal & scope

1.2.Research assumptions

1.3.Research Methodology

1.3.1.Primary data sources

1.3.2.Secondary data sources

1.4.Key take-aways

1.5.Stakeholders

2.Executive Summary

2.1.Market Definition

2.2.Market Segmentation

3.Global Scaffold Technology Market Insights

3.1.Scaffold Technology Market – Industry snapshot

3.2.Scaffold Technology Market – Ecosystem analysis

3.3.Scaffold Technology Market – Market dynamics

3.3.1.Scaffold Technology Market – Market Forces

3.3.1.1.Scaffold Technology Market - Market driver analysis

3.3.1.2.Scaffold Technology Market - Market restraint/challenges analysis

3.3.1.3.Scaffold Technology Market - Market opportunity analysis

3.4.Industry analysis - Porter's five force

3.4.1.Bargaining power of supplier

3.4.2.Bargaining power of buyer

3.4.3.Threat of substitute

3.4.4.Threat of new entrant

3.4.5.Degree of competition

3.5.Scaffold Technology Market PEST analysis, 2017

3.6.Value Chain Analysis

3.7.Gout Therapeutics Market Industry trends

4.Scaffold Technology Market Size and Forecast by Product Type

4.1.Key findings

4.2.Polymeric Scaffolds

4.3.Hydrogels

4.4.Micro patterned Surface Microplates

4.5.Freeze Embryo Testing

4.6.Nanofiber-based Scaffolds

5.Scaffold Technology Market Size and Forecast by Application Type

5.1.Key findings

5.2.Drug Development

5.3.Stem Cell Research

5.4.Cancer

5.5.Tissue engineering and clinical application

5.6.Others

6.Scaffold Technology Market Size and Forecast by Application Type

6.1.Key findings

6.2.Research Laboratories & Institutes

6.3.Biotechnology and pharmaceutical Organizations

6.4.Hospital & Diagnostics Centre

6.5.Others

7.Scaffold Technology Market Size and Forecast by Regions

7.1.Key findings

7.2.North America

7.2.1.US.

7.2.2.Canada

7.3.Europe

7.3.1.Germany

7.3.2.UK

7.4.Asia Pacific

7.4.1.China

7.4.2.India

7.4.3.Japan

7.5.Latin America

7.5.1.Brazil

7.5.2.Middle East & Africa

8.Company Profiles

8.1.Merck and Company

8.1.1.Overview

8.1.2.Financials

8.1.3.Product Type Benchmarking

8.1.4.Recent Developments

8.2.Thermo Fisher Scientific Inc.

8.2.1.Overview

8.2.2.Financials

8.2.3.Product Type Benchmarking

8.2.4.Recent Developments

8.3.3D Biotek LLC

8.3.1.Overview

8.3.2.Financials

8.3.3.Product Type Benchmarking

8.3.4.Recent Developments

8.4.Pelo Bioteh GmbH

8.4.1.Overview

8.4.2.Financials

8.4.3.Product Type Benchmarking

8.4.4.Recent Developments

8.5.Corning Inc.

8.5.1.Overview

8.5.2.Financials

8.5.3.Product Type Benchmarking

8.5.4.Recent Developments

8.6.Becton, Dickson & Company

8.6.1.Overview

8.6.2.Financials

8.6.3.Product Type Benchmarking

8.6.4.Recent Developments

8.7.Avacta Lifesciences Limited.

8.7.1.Overview

8.7.2.Financials

8.7.3.Product Type Benchmarking

8.8.Nanofiber Solutions

8.8.1.Overview

8.8.2.Financials

8.8.3.Product Type Benchmarking

8.8.4.Recent Developments

8.9.Nuvasive Inc.

8.9.1.Overview

8.9.2.Financials

8.9.3.Product Type Benchmarking

8.9.4.Recent Developments

8.10.ReproCELL Europe Ltd.

8.10.1.Overview

8.10.2.Financials

8.10.3.Product Type Benchmarking

8.10.4.Recent Developments

8.11.Marticel GmbH

8.11.1.Overview

8.11.2.Financials

8.11.3.Product Type Benchmarking

8.11.4.Recent Developments

8.12.Tecan Trading AG.

8.12.1.Overview

8.12.2.Financials

8.12.3.Product Type Benchmarking

8.12.4.Recent Developments

8.13.Molecular Matrix Inc.

8.13.1.Overview

8.13.2.Financials

8.13.3.Product Type Benchmarking

8.13.4.Recent Developments


All Fields are mandatory*

Name: *
Email Id: *
Job Title: *
Company: *
Phone: *
Country: *
Message: *

PLEASE SELECT A LICENSE TYPE

Single User $4500
Multi User $6500
Corporate User $8500

Related Reports

Scroll to Top